Title: Anti-CYP11A1 Polyclonal Antibody: A Powerful Tool for Studying Steroid Biosynthesis
Introduction:
Anti-CYP11A1 Polyclonal Antibody is a highly specific and sensitive tool for research in the field of steroid biosynthesis. This antibody is designed to target the enzyme CYP11A1, which plays a crucial role in the production of steroid hormones. With its high affinity and specificity, this antibody is an essential tool for studying the function and regulation of CYP11A1 in various physiological and pathological conditions.
Biological Function:
CYP11A1, also known as cytochrome P450 side-chain cleavage enzyme, is a key enzyme in the biosynthesis of steroid hormones. It catalyzes the conversion of cholesterol into pregnenolone, the precursor of all steroid hormones. CYP11A1 is predominantly expressed in the adrenal cortex and gonads, but it is also found in other tissues such as the brain, placenta, and skin. Dysregulation of CYP11A1 has been linked to various disorders, including adrenal insufficiency and hormone-dependent cancers.
Main Applications:
Anti-CYP11A1 Polyclonal Antibody is widely used in research on steroid biosynthesis and related disorders. It has been successfully applied in immunohistochemistry, western blotting, and enzyme activity assays. This antibody is suitable for use in various species, including human, mouse, and rat.
Experimental Use Cases:
– Investigating the role of CYP11A1 in steroid hormone production: By targeting CYP11A1, this antibody allows researchers to study the function of this enzyme in the biosynthesis of different steroid hormones, including cortisol, aldosterone, and sex hormones.
– Examining the expression and distribution of CYP11A1 in various tissues: With its high specificity, this antibody is an excellent tool for visualizing the localization of CYP11A1 in different tissues and cell types.
– Studying the regulation of CYP11A1 in diseases: Dysregulation of CYP11A1 has been implicated in various diseases, such as adrenal insufficiency and hormone-dependent cancers. This antibody can help researchers understand the mechanisms underlying these disorders.
– Developing therapeutic strategies: Targeting CYP11A1 has been proposed as a potential therapeutic strategy for hormone-dependent cancers. This antibody can be used to screen for compounds that can inhibit or modulate the activity of CYP11A1.
In summary, Anti-CYP11A1 Polyclonal Antibody is a reliable and versatile tool for studying the function and regulation of CYP11A1 in steroid biosynthesis. Its high specificity and sensitivity make it an essential reagent for researchers in the field of endocrinology, cancer biology, and drug discovery. Order now and take your research to the next level.
There are no reviews yet.